COVIDIEN MFG DC BOULDER
Manufacturer adverse-event records for COVIDIEN MFG DC BOULDER come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.
FDA MAUDE device safety record · 2017–2025 · mid-book · typical Death-code · balanced
Injury-mix signature
COVIDIEN MFG DC BOULDER keeps a balanced Injury share
Injury-coded event_type share is 10.9% (balanced tercile) beside 0.58% Death-coded (typical). Volume band: mid.
What the Injury-mix reading shows for COVIDIEN MFG DC BOULDER
The standout signal for COVIDIEN MFG DC BOULDER is Injury-mix: 10.9% Injury-coded (balanced) beside 0.58% Death-coded, on a mid-book footprint.
Mid-pack volume still shows a clear device fingerprint; the table below is the actionable layer for COVIDIEN MFG DC BOULDER. Event_type Death/Injury codes differ from patient-outcome rows - see methodology.
Reports span 20 device types, led in this extract by Malfunction at 12,517 (88.5% of event_type total). Peak single-year volume reaches 2,274 reports across 9 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.
Event Types
Patient Outcomes
FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.
Devices (20)
Yearly Trend
Read our methodology - how this data is sourced, computed, and verified.